Diagnostic and Classification Criteria in Endocarditis

1. Modified Duke Criteria

The Modified Duke Criteria represent the cornerstone of diagnosis for infective endocarditis (IE), integrating clinical, microbiologic, and echocardiographic findings into a standardized framework. This system allows for a consistent approach to classifying patients.

Major Criteria

Blood Cultures: Two positive blood cultures for typical IE organisms (e.g., viridans group streptococci, Streptococcus bovis group, HACEK group, Staphylococcus aureus, or community-acquired enterococci) drawn from separate sites at least one hour apart.
Evidence of Endocardial Involvement: Echocardiographic findings such as an oscillating intracardiac mass (vegetation), abscess, new partial dehiscence of a prosthetic valve, or new-onset valvular regurgitation.

Minor Criteria

Predisposition: A known predisposing heart condition or history of injection drug use.
Fever: Temperature greater than 38°C (100.4°F).
Vascular Phenomena: Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, or Janeway lesions.
Immunologic Phenomena: Glomerulonephritis, Osler nodes, Roth spots, or a positive rheumatoid factor.
Microbiologic Evidence: A positive blood culture that does not meet the major criterion.

Diagnostic Classification

Diagnostic Classification using Modified Duke Criteria
Classification	Required Criteria
Definite IE	2 Major Criteria OR 1 Major + 3 Minor Criteria OR 5 Minor Criteria
Possible IE	1 Major + 1 Minor Criterion OR 3 Minor Criteria
Rejected IE	Does not meet the criteria for Definite or Possible IE, or an alternative diagnosis is confirmed.

Clinical Pearl: Enhancing Diagnostic Sensitivity +

Modern guidelines have expanded the major criteria to enhance sensitivity. Including serology for fastidious organisms (e.g., Coxiella burnetii phase I IgG ≥1:800) or identifying new-onset prosthetic valve endocarditis via advanced imaging (like PET/CT) can upgrade a “possible” case to “definite.” Remember that up to 30% of true IE cases may not meet “definite” criteria initially, so a high index of clinical suspicion is crucial, especially when initial tests are negative.

2. Microbiologic Diagnostics

Prompt and accurate identification of the causative pathogen is critical for directing antimicrobial therapy and improving outcomes. Best practices in sample collection are paramount.

Blood Culture Best Practices

Obtain at least three sets of blood cultures from separate venipuncture sites.
The first and last draws should be separated by at least one hour to demonstrate continuous bacteremia.
Cultures should ideally be drawn before initiating antibiotic therapy, if the patient is hemodynamically stable.
Utilize rapid identification technologies like MALDI-TOF MS to accelerate organism identification and subsequent susceptibility testing.

Navigating Culture-Negative Endocarditis

When blood cultures are persistently negative despite high clinical suspicion, adjunctive testing is necessary:

Serologic Assays: Test for fastidious organisms that do not grow in standard culture media, such as Bartonella spp., Brucella spp., and Coxiella burnetii.
Molecular Testing: Polymerase chain reaction (PCR) performed on excised valve tissue or, in some cases, whole blood can identify pathogen DNA. While not formally part of the Duke criteria, it is a powerful adjunctive tool.

Clinical Pearl: The Stability-Culture Dilemma +

The decision to delay antibiotics to obtain optimal cultures is a critical judgment call. In a hemodynamically stable patient, waiting an hour or more to collect all culture sets significantly increases diagnostic yield. However, in a patient with sepsis or shock, immediate administration of broad-spectrum antibiotics after drawing the initial cultures is a life-saving priority. The diagnostic benefit never outweighs the risk of clinical decompensation.

3. Echocardiographic Imaging

Echocardiography is the imaging cornerstone for diagnosing IE and its complications. The choice between transthoracic (TTE) and transesophageal (TEE) approaches depends on patient factors and the specific clinical question.

Transthoracic vs. Transesophageal Echocardiography

Comparison of TTE and TEE in Infective Endocarditis
Feature	Transthoracic Echo (TTE)	Transesophageal Echo (TEE)
Role	First-line, noninvasive screening	Problem-solving, high-risk cases
Sensitivity (Native Valve)	50–70%	>90%
Sensitivity (Prosthetic Valve)	40–50% (often limited by artifact)	>90%
Indications	Initial evaluation in most patients	Negative TTE with high suspicion, all prosthetic valves, suspected complications (abscess, perforation)
Limitations	Poor acoustic windows (obesity, COPD), mechanical ventilation	Invasive, requires sedation, contraindications (esophageal disease)

Advanced Echocardiographic Techniques

3D Echocardiography, particularly with TEE, provides superior anatomical detail of vegetation size, shape, and mobility, which is invaluable for surgical planning. Cardiac CT and MRI serve as important adjuncts when echo is inconclusive, especially for evaluating perivalvular extension of infection into surrounding tissues.

Clinical Pearl: When to Escalate to TEE +

A negative TTE does not rule out endocarditis, especially in high-risk scenarios. If clinical suspicion remains high after a non-diagnostic TTE, proceed to TEE without delay. A reasonable timeframe is within 3-5 days for stable patients, but it should be performed immediately if the patient develops new heart failure, heart block, or embolic events, as these suggest a developing complication that TEE is best suited to detect.

4. Advanced Imaging Adjuncts

In complex cases, particularly involving prosthetic valves (PVE) or cardiac implantable electronic devices (CIEDs), echocardiography may be inconclusive. Nuclear imaging has emerged as a critical tool to resolve diagnostic uncertainty.

¹⁸F-FDG PET/CT and Leukocyte SPECT/CT

These functional imaging modalities detect metabolic activity (inflammation) associated with infection. Their primary role is in suspected PVE or CIED infections where echo findings are equivocal. Focal radiotracer uptake around a prosthetic valve or device lead is a strong indicator of infection.

¹⁸F-FDG PET/CT Yes

Figure 1: Simplified Imaging Algorithm in Suspected Endocarditis. This demonstrates the sequential use of imaging, starting with TTE and escalating to TEE and then advanced modalities like PET/CT for complex cases such as prosthetic valve endocarditis (PVE).

Clinical Pearl: Patient Prep for PET/CT is Key +

The utility of ¹⁸F-FDG PET/CT is highly dependent on suppressing physiologic glucose uptake by the heart muscle, which can otherwise mask or mimic signs of infection. Strict patient preparation is mandatory and typically includes a prolonged fasting period (at least 6 hours) and a high-fat, low-carbohydrate diet for 24-48 hours prior to the scan. Failure to adhere to these protocols is a common cause of false-positive or uninterpretable results.

5. Classification and Risk Stratification

Beyond diagnosis, classifying IE and stratifying risk are essential for determining the urgency of management, particularly the need for surgical intervention.

Key Classification Schemes

Native vs. Prosthetic Valve IE (PVE): PVE carries a higher mortality and complication rate, often caused by more virulent organisms like staphylococci. Early PVE (<1 year post-op) is typically nosocomial, while late PVE resembles native valve IE.
Left-Sided vs. Right-Sided IE: Left-sided (mitral, aortic) IE poses a risk of systemic embolization (e.g., stroke) and severe heart failure. Right-sided (tricuspid) IE is classic in persons who inject drugs and typically presents with septic pulmonary emboli.

Predicting Embolic Risk and Mortality

Certain features significantly increase the risk of embolization and poor outcomes. Formal scoring systems can help quantify this risk and facilitate multidisciplinary discussions about the timing of surgery.

Key Predictors and Formal Risk Scores in IE
Risk Factor / Score	Components / Interpretation
High Embolic Risk Predictors	Vegetation size >10 mm, high mobility, involvement of the anterior mitral leaflet, and infection with S. aureus or Candida spp.
PALSUSE Score	Predicts 6-month mortality. Acronym for: Prosthesis, Age, Large vegetations, Surgery urgency, Uncontrolled infection, Staphylococcus, Emboli.
STS-IE Score	Society of Thoracic Surgeons score that estimates in-hospital or 30-day operative mortality for patients undergoing surgery for IE. Uses numerous clinical and echo variables.

Clinical Pearl: Early Surgical Consultation is Not a Commitment to Operate +

For any patient with high-risk features—such as large vegetations (>10 mm), signs of heart failure, or perivalvular extension—an early surgical consultation is mandatory. This does not commit the patient to an operation but rather engages the multidisciplinary Heart Team early. This allows for proactive planning so that if the patient deteriorates, a well-considered surgical plan can be executed urgently rather than emergently, which is associated with better outcomes.

References

Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement from the AHA. Circulation. 2015;132(15):1435–1486.
Heidenreich PA, Masoudi FA, Maini B, et al. Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med. 1999;107(3):198–208.
Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33(7):2023–2029.
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075–3128.
Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466–2473.
Iversen K, Ihlemann N, Gill SU, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380(5):415–424.

Learning Objective